Newsletter | March 21, 2026
FEATURED EDITORIAL
Advising The Biotech C-Suite To Reconsider Quality
By Louis Garguilo, chief editor, Outsourced Pharma
The Hidden Engineering Behind Successful Upstream Bioprocessing
By Smiriti Gupta, NIRAS
Not So Fast Into The Night: Your Outsourcing Needs A Pause
To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
By Victor Lien, Cell & Gene
A Biotech Business Model That's Investor-Friendly
5 QMS Blind Spots You Should Know About
By Kyle Winn and Adam Walker, W2 Cleanroom Consulting
The Long Road To U.S. Vaccine Manufacturing
Dynamic Flux Analysis Offers Faster Metabolic Modeling Than DOE
A conversation with Hardik Dodia, Ph.D.
A Woman Relegated To The Manufacturing Night Shift
Where Contamination Control Really Breaks Down In Practice
INDUSTRY INSIGHTS
Mirror, Mirror Makes RNA-targeted Discovery Smarter
By Zhen Chen, X-Chem
Qualities Of A CDMO Redefining Innovation
Grand River Aseptic Manufacturing
Why CROs Need A New Operating System
By Ander Tallett, Dash Bio
Essential Insights Into Linker Chemistry For ADCs
Abzena
From Syringes To Wearables: Formulation's Impact
Andreas Stelzl, Ph.D. and Eva Keilhauer, Ph.D., Coriolis Pharma
CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever
By Miguel Ángel Ortega Sánchez, ROIS
Interchangeability Assessment And Qualification Best Practice Guide
BioPhorum
Global Reach, Biotech Speed: Clinical Packaging, Labeling That Delivers
Thermo Fisher Scientific
De-Risking FDA Abbreviated New Drug Application (ANDA) Submissions
BD Medical - Pharmaceutical Systems
Solid‑State HDX For ADC Stability
Simtra BioPharma Solutions
Scale-Up And BLA Planning For Microbial Biomanufacturing
Lonza
Application Of Plant And Process Models
Boehringer Ingelheim Biopharmaceuticals GmbH
The Next Frontier In mRNA
Cytiva
How To Design And Evaluate Bispecific Antibodies (BsAbs)?
ProBio
Engineering Rep-Cap Plasmids To Enhance AAV Manufacturability, Potency
By Xiaojun Liu, Yeonji Kim, Chris Brown, and Jing Zhu, Recipharm Advanced Bio
Partnering For Success In Oncolytic Virus Development
By Michael Baker, FUJIFILM Biotechnologies
Why Flexible, Collaborative Distribution Partners Matter For CGTs
Cencora
Viral Vectors: The Backbone Of Cell And Gene Therapy
Landmark Bio
New Technology Platforms Being Developed
Vector BioMed
Defining The Required CQAs For mRNA/LNP Product Development
Navigating Lentiviral Therapy Commercialization
By Jiasong Jiang, Leila M. Aneke, F. Michael Haller, et al., Lonza
Time: A Crucial Factor In Therapeutics Development
Aldevron
Revolutionizing Gene Therapy Manufacturing
Navigating The New USP Chapter <382> For Elastomeric Closures
Alcami
Right From The Start: Smarter Developability For Stronger Formulations
By Nazar Elkarim, Ph.D., Mikart
Ensuring The Compliant Manufacture Of Highly Potent Drug Products
Altasciences
Silencing CDMO Project Noise: The Power Of Low-Drama Drug Development
By Susan Lynch-Smith, Douglas CDMO
Advancing Drug Development Using In Silico Modeling
Three Considerations For New Drug Developers
Curia
Expertise And Transparency Drive A Distinct Development Journey
By David Wood, Experic
The Principles Of Green Chemistry: Reduce Derivatives
SK pharmteco
A Proven Approach To Impurity Control Across API And RSM Synthesis
Grace Fine Chemical Manufacturing Services
Optimization Of A Glycosylation Analytical Method
By Eliza Yeung, Ph.D. and Philip Ramsey, Ph.D., Cytovance Biologics
Optimize Your CLD With Innovative And Flexible Transposase Technology
KBI Biopharma
Getting To The Heart Of CDMO Tech Transfer Excellence
Bora Pharmaceuticals
Developing New Medicines Through Artificial Intelligence
By Tony Reina, Resilience, LLC.
Solving Atypical Protein Expression With Transposases
By Kayla Bean, AGC Biologics
Scaling Manufacturing Flexibility For Fill-Finish Commercial Success
Jubilant HollisterStier
End-To-End Biologics Support
Human Performance In Pharma: Strengthening The Biotech Workforce
CAI
Supply Resiliency For Bioprocessing Amid Global Volatility
Charting A Successful CMC Journey For Your ADC Drug Product
Expanding Opportunities For Inhaled Drug Delivery
By Gunilla Petersson, Ph.D., Nanoform
Ensuring The Efficacy Of Probiotic Products
Ropack Pharma Solutions
Accelerated Development Of Solid Oral Dosage Formulation
By Saujanya Gosangari, Alcami
Transforming Environmental Monitoring And Sample Management
Eurofins PSS Insourcing Solutions
5 Advancements In Tablet Compression That Pharma Can't Ignore In 2026
By Tony Beal, Natoli Engineering Company, Inc.
Patient-Centric Formulations In Pediatric Adherence
By Srinivasan Shanmugam, Ph.D., Adare Pharma Solutions
Challenges In ADC Production — Consolidating Operations Under One Roof
By Jin Seog Seo, Omar Ahmed, and Tariq Massad, Eurofins
Dry Powder Inhalable Vaccines For Shelf Stability And Global Access
